Conflict of interest in oncology publications: A survey of disclosure policies and statements

Cancer

Volumn 118, Issue 1, 2012, Pages 188-195

  Kesselheim, Aaron S ^a   Lee, Joy L ^a   Avorn, Jerry ^a   Servi, Amber ^a   Shrank, William H ^a   Choudhry, Niteesh K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

clinical oncology; conflict of interest; disclosure; publishing

Indexed keywords

CONFLICT OF INTEREST; INTERPERSONAL COMMUNICATION; JOURNAL IMPACT FACTOR; MEDICAL LITERATURE; ONCOLOGY; POLICY; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; REVIEW;

AUTHORSHIP; CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; MEDICAL ONCOLOGY; PUBLICATIONS;

EID: 83855162904     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26237     Document Type: Review

References (43)

1. Institute of Medicine, Board on Health Sciences Policy. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: NAS Press; 2009.
2. Lexchin J, Bero LA, Djulbegovic B, Clark O,. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003; 326: 1167-1170. (Pubitemid 36649048)
3. Bekelman JE, Li Y, Gross CP,. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003; 289: 454-465. (Pubitemid 36119966)
4. Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA,. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry. 2005; 162: 1957-1960. (Pubitemid 41428627)
5. Kelly RE Jr, Cohen LJ, Semple RJ, et al. Relationship between drug company funding and outcomes of clinical psychiatric research. Psychol Med. 2006; 36: 1647-1656. (Pubitemid 44575810)
6. Ridker PM, Torres J,. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA. 2006; 295: 2270-2274. (Pubitemid 43736577)
7. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS,. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med. 2007; 4: e5-e5.
8. Leopold SS, Warme WJ, Fritz Braunlich E, Shott S,. Association between funding source and study outcome in orthopaedic research. Clin Orthop Relat Res. 2003; 415: 293-301. (Pubitemid 37329067)
9. Peppercorn J, Blood E, Winer E, Partridge A,. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer. 2007; 109: 1239-1246. (Pubitemid 46466549)
10. Sage WM,. Some principles require principals: why banning "conflicts of interest" won't solve incentive problems in biomedical research. Texas Law Rev. 2007; 85: 1413-1463.
11. Rowan-Legg A, Weijer C, Gao J, Fernandez C,. A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005. J Med Ethics. 2009; 35: 74-78.
12. Bates T, AniÄ A, MarusiÄ M, MarusiÄ A,. Authorship criteria and disclosure of contributions: comparison of 3 general medical journals with different author contribution forms. JAMA. 2004; 292: 86-88. (Pubitemid 38923798)
13. Harris G,. Cigarette company paid for lung cancer study. N Y Times. March 26, 2008: A1.
14. Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC,. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA. 1994; 272: 108-113. (Pubitemid 24206039)
15. Citrome L,. Citability of original research and reviews in journals and their sponsored supplements. PLoS One. 2010; 5: e9876.
16. Drazen JM, Van der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med. 2009; 361: 1896-1897.
17. Drazen JM, de Leeuw PW, Laine C, et al. Toward more uniform conflict disclosures-the updated ICMJE conflict of interest reporting form. N Engl J Med. 2010; 363: 188-189.
18. Blum JA, Freeman K, Dart RC, Cooper RJ,. Requirements and definitions in conflict of interest policies of medical journals. JAMA. 2009; 302: 2230-2234.
19. Winfurt KP, Seils DM, Tzeng JP, Lin L, Schulman KA, Califf RM,. Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents. PloS ONE. 2008; 3: e2128.
20. Meerpohl JJ, Wolff RF, Niemeyer CM, Antes G, von Elm E,. Editorial policies of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc Med. 2010; 164: 268-272.
21. Hampson LA, Joffe S, Fowler R, Verter J, Emanuel EJ,. Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol. 2007; 25: 3609-3614. (Pubitemid 47372598)
22. Djulbegovic B, Angelotta C, Knox KE, Bennett CL,. The sound and the fury: financial conflicts of interest in oncology. J Clin Oncol. 2007; 25: 3567-3569. (Pubitemid 47372591)
23. Riechelmann RP, Wang L, O'Carroll A, Krzyzanowska MK,. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol. 2007; 25: 4642-4647. (Pubitemid 350035325)
24. Jagsi R, Sheets N, Jankovic A, Motomura AR, Amarnath S, Ubel PA,. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer. 2009; 115: 2783-2791.
25. Garfield E,. The history and meaning of the journal impact factor. JAMA. 2006; 295: 90-93. (Pubitemid 43042694)
26. Callaham M, Wears RL, Weber E,. Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA. 2002; 287: 2847-2850. (Pubitemid 34591981)
27. Nakayama T, Fukui T, Fukuhara S, Tsutani K, Yamazaki S,. Comparison between impact factors and citations in evidence-based practice guidelines. JAMA. 2003; 290: 755-756. (Pubitemid 37432949)
28. Kincaid JP, Fishburne RP, Rogers RL, Chissom BS,. Derivation of New Readability Formulas (Automated Readability Index, Fog Count, and Flesch Reading Ease Formula) for Navy Enlisted Personnel. Memphis, TN: Naval Air Station; 1975.
29. Altman DG,. Practical Statistics for Medical Research. London, UK: Chapman and Hall; 1991.
30. Wilkes MS, Kravitz RL,. Policies, practices, and attitudes of North American medical journal editors. J Gen Intern Med. 1995; 10: 443-450.
31. Tatsioni A, Siontis GC, Ioannidis JP,. Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy. J Gen Intern Med. 2010; 25: 914-919.
32. Kesselheim AS, Misono AS, Lee JL, et al. The clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2009; 300: 2514-2526.
33. Lichtblau E,. Justice Thomas' wife sets up a conservative lobbying shop. N Y Times. February 4, 2011, A11.
34. Nocera J,. A double standard at H.P.: editors' note. N Y Times. October 8, 2010. Available at: Accessed March 1, 2011.
35. Chung S, Palaniappan LP, Trujillo LM, Rubin HR, Luft HS,. Effect of physician-specific pay-for-performance incentives in a large group practice. Am J Manag Care. 2010; 16: e35-e42.
36. Give up the ghosts. Nature. 2010; 468: 732.
37. Chimonas S, Frosch Z, Rothman DJ,. From disclosure to transparency: the use of company payment data. Arch Intern Med. 2011; 171: 81-86.
38. Chaudhry S, Schroter S, Smith R, Morris J,. Does declaration of competing interests affect readers' perceptions? A randomised trial. BMJ. 2002; 325: 1391-1392. (Pubitemid 35477844)
39. Schroter S, Morris J, Chaudhry S, Smith R, Barratt H,. Does the type of competing interest statement affect readers' perceptions of the credibility of research? A randomised trial. BMJ. 2004; 328: 742-743. (Pubitemid 38406427)
40. Silverman GK, Loewenstein GF, Anderson BL, Ubel PA, Zinberg S, Schulkin J,. Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians. J Med Ethics. 2010; 36: 265-270.
41. Cain DM, Loewenstein G, Moore DA,. The dirt on coming clean: perverse effects of disclosing conflicts of interest. J Legal Stud. 2005; 34: 1-25. (Pubitemid 40549835)
42. Cain DM, Detsky AS,. Everyone's a little bit biased (even physicians). JAMA. 2008; 299: 2893-2895. (Pubitemid 351930890)
43. Wager E, Mhaskar R, Warburton S, Djulbegovic B,. JAMA published fewer industry-funded studies after introducing a requirement for independent statistical analysis. PLoS One. 2010; 5: e13591.